Cardiotoxicity of Cancer Therapy (CCT)

Enrolling by invitationOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2037

Study Completion Date

April 30, 2037

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Echocardiography

Prior to chemotherapy, prior to and after anthracyclines, every 6 weeks during trastuzumab, and yearly for up to 10 years.

OTHER

Blood Collection

Drawn at first chemo treatment and periodically during treatment (exact schedule varies with clinically ordered treatment plan), then annually for up to 10 years. Blood is banked for future biomarker testing.

OTHER

Symptoms Questionnaire

Survey collected at first chemotherapy, periodically during therapy (exact schedule determined by clinically ordered treatment regimen), and annually for up to 10 years.

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER